Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shexiang Baoxin Pill
- Development stage
- Phase 4
- Lead developer
- Shanghai Hutchison Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Shexiang Baoxin Pill (SXBXP) is a widely used Traditional Chinese Medicine (TCM) formula primarily indicated for the treatment of cardiovascular diseases, including stable angina pectoris and coronary heart disease. It is composed of seven ingredients: artificial musk, ginseng, styrax, cinnamon bark, toad venom, calculus bovis, and borneol. The drug exerts its therapeutic effects through multiple mechanisms, including the promotion of angiogenesis (via upregulation of VEGF and bFGF), improvement of vascular endothelial function, reduction of inflammatory responses, and regulation of lipid metabolism. It has been extensively studied in China, including the large-scale MUST trial, which demonstrated its safety and efficacy in reducing major adverse cardiovascular events (MACE) in patients with stable coronary artery disease.
- Brand names
- Shexiang Baoxin PillShexiang Baoxin Wan
- Other names
- Musk Heart-Protecting PillSXBXP
02
Targets
CYP2B6 (Cytochrome P450 2B6)CYP2C19 (Cytochrome P450 2C19)OATP1B1 (Organic anion transporting polypeptide 1B1)
Beyond the preview
Go deeper on Shexiang Baoxin Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shexiang Baoxin Pill.